Rankings
▼
Calendar
SAVA Q1 2016 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SAVA
Cassava Sciences, Inc.
$115M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$3,595
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-0.89
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$29M
Total Liabilities
$3M
Stockholders' Equity
$25M
Cash & Equivalents
$27M
← FY 2016
All Quarters
Q2 2016 →
